Want to join the conversation?
$DXPE said that it managed expenses tightly in 2Q16 given the continued low sales volume. SG&A expenses declined significantly YoverY due to the company's focus on managing costs and maximizing its sales efforts to grow. Free cash flow for the quarter was $17.7MM.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)